Avidity Partners Management LP Immunic, Inc. Transaction History
Avidity Partners Management LP
- $2.03 Billion
- Q2 2024
A detailed history of Avidity Partners Management LP transactions in Immunic, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 8,902,972 shares of IMUX stock, worth $10.5 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
8,902,972
Previous 8,902,972
-0.0%
Holding current value
$10.5 Million
Previous $11.8 Million
15.91%
% of portfolio
0.49%
Previous 0.45%
Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
67Shares Held
56MCall Options Held
4.7KPut Options Held
311K-
Bvf Inc San Francisco, CA8.9MShares$10.5 Million0.3% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$8.61 Million0.82% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$8.35 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$6.6 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$5.39 Million0.08% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $36.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...